Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02352103 · ClinicalTrials.gov registry record · Phase 3
Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery
A Phase 3 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
NCT02352103 is a Phase 3 study that has completed, run by Henry Ford Health System. The registered enrollment target is 120 participants.
The verdict
NCT02352103, a Phase 3 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
Study Summary
To assess and compare the short-term post-operative continence recovery rate in two cohorts of men undergoing Robot Assisted Radical Prostatectomy (RARP), each randomized to undergo RARP with Vattikuti Institute technique or Retzius sparing technique.
Interventions
- PROCEDURE Retzius sparing radical prostatectomy
- PROCEDURE Vattikuti Urology Institute radical prostatectomy
- DEVICE da Vinci Surgical System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02352103
The ClinicalTrials.gov registry entry for NCT02352103 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Retzius sparing radical prostatectomy is the first listed.
NCT02352103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02352103 about?
NCT02352103 is a clinical study titled "Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery". To assess and compare the short-term post-operative continence recovery rate in two cohorts of men undergoing Robot Assisted Radical Prostatectomy (RARP), each randomized to undergo RARP with Vattikuti Institute technique or Retzius sparing technique.
What is the current status of trial NCT02352103?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2015-01. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02352103?
The interventions under investigation include: Retzius sparing radical prostatectomy (PROCEDURE), Vattikuti Urology Institute radical prostatectomy (PROCEDURE), da Vinci Surgical System (DEVICE).
Who is sponsoring clinical trial NCT02352103?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.